NCT04184297View on ClinicalTrials.gov

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

CompletedOBSERVATIONAL
Enrollment

27,190

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 4, 2019

Study Completion Date

November 4, 2019

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium and Olodaterol (Tio+Olo)

drug

DRUG

Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)

drug

Trial Locations (1)

01810

HealthCore, Inc., Andover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY